Lexaria Bioscience (LEXX) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Lexaria Bioscience has announced a $5 million registered direct offering, pricing its shares at-the-market under Nasdaq rules. The company will also issue unregistered warrants for additional shares, with proceeds intended for working capital and corporate purposes. H.C. Wainwright & Co. is acting as the exclusive placement agent for this offering.
For further insights into LEXX stock, check out TipRanks’ Stock Analysis page.
